Search

Helpdesk

Sales contact

Home > Resources > Working with patient associations: What is the key to a positive interaction?

Working with patient associations: What is the key to a positive interaction?

Patients insights Rare disease

Last updated: April 13, 2026

What rare disease patients and families want is a simpler life.
Discover here what makes the relationship between the members of the patients’ association and a company work so well.

Follow us on social media

Subscribe to our newsletter

You may also like

Kayentis publishes its first ESG report, strengthening its commitment to...

Kayentis launches interactive eConsent solution to simplify and improve patient...

Better Raters, Smarter eCOA, Stronger Data

Strengthening Endpoint Reliability: An Interview with Estelle Haenel, Chief Medical...

Kayentis and RWS join forces to improve data confidence in...

What if eCOA could elevate your next rare disease trial?

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

SCOPE Europe 2026

OCT 13-14 2026 • Barcelona, Spain

Meet our team Chris BARDEN and Björn FELBER at SCOPE Europe Schedule a meeting

ISOQOL 2026

18-21 OCT 2026 • Prague, Czech Republic

33rd Annual Conference | ISOQOL